Synthesis of N-acetyl-D-galactosamine and folic acid conjugated ribozymes

Bioconjugate Chemistry

Volumn 13, Issue 5, 2002, Pages 1071-1078

  Matulic Adamic, Jasenka ^a   Serebryany, Vladimir ^a   Haeberli, Peter ^a   Mokler, Victor R ^a   Beigelman, Leonid ^a  

^a Sirna Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDES; SYNTHESIS (CHEMICAL);

CELLULAR UPTAKE; D-GALACTOSAMINE; FOLIC ACIDS; HEPATOCYTES; N ACETYLS; OLIGONUCLEOTIDE CONJUGATES; PHOSPHORAMIDITES; RIBOZYMES; SOLID PHASE SYNTHESIS; TISSUE SPECIFICS;

AMINO ACIDS;

ANTINEOPLASTIC AGENT; CROSS LINKING REAGENT; FOLIC ACID; N ACETYLGALACTOSAMINE; OLIGONUCLEOTIDE; ORGANOPHOSPHORUS COMPOUND; PHOSPHORAMIDOUS ACID; RIBOZYME;

ARTICLE; CHEMISTRY; DRUG DELIVERY SYSTEM; METHODOLOGY; SYNTHESIS;

ACETYLGALACTOSAMINE; ANTINEOPLASTIC AGENTS; CROSS-LINKING REAGENTS; DRUG DELIVERY SYSTEMS; FOLIC ACID; OLIGONUCLEOTIDES; ORGANOPHOSPHORUS COMPOUNDS; RNA, CATALYTIC;

EID: 0036738585     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc025525q     Document Type: Article

References (36)

1. Kruger, K., Grabowski, P. J., Zaug, A. J., Sands, J.; Gottschling, D. E., and Cech, T. R. (1982) Self-splicing RNA: Autoexcision and autocyclization of the ribosomal RNA intervening sequence. Cell 31, 147-157.
2. Guerrier-Takada, C., Gardiner, K., Marsh, T., Pace, N., and Altman, S. (1983) The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35, 849-857.
3. Christoffersen, R. E., and Marr, J. J. (1955) Ribozymes as human therapeutic agents. J. Med. Chem. 38, 2024-2037.
4. Beigelman, L., McSwiggen, J. A., Draper, K. G., Gonzalez, C., Jensen, K., Karpeisky, A. M., Modak, A. S., Matulic-Adamic, J., DiRenzo, A. B., Haeberli, P., Sweedler, D., Tracz, D., Grimm, S., Wincott, F. E., Thackray, V. G., and Usman, N. (1995) Chemical modification of hammerhead ribozymes. J. Biol. Chem. 43, 25702-25708.
5. Paolella, G., Sproat, B. S., and Lamond, A. I. (1992) Nuclease-resistant ribozyme with high catalytic activity. EMBO J. 11, 1913-1919.
6. Akhtar, S., Hughes, M. D., Khan, A., Bibby, M., Hussain, M., Nawaz, Q., Double, J., and Sayyed, P. (2000) The delivery of antisense therapeutics. Adv. Drug Deliv. Rev. 44, 3-21 and references therein.
7. Dokka, S., and Rojanasakul, Y. (2000) Novel nonendocytic delivery of antisense oligonucleotides. Adv. Drug Deliv. Rev. 44, 35-49 and references therein.
8. Wu, G. Y., and Wu, C. H. (1987) Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262, 4429-4432.
9. Baenziger, J., and Fiete, D. (1980) Galactose and N-acetylgalactosamine-specific endocytosis of glycopeptides by isolated rat hepatocytes. Cell 22, 611-620.
10. Connolly, D. T., Townsend, R. R., Kawakuchi, K., Bell, W. R., and Lee, Y. C. (1982) Binding and endocytosis of cluster glycosides by rabbit hepatocytes. J. Biol. Chem. 257, 939-945.
11. Lee, R. T., and Lee, Y. C. (1987) Preparation of cluster glycosides of N-acetylgalactosamine that have subnanomolar binding constants toward the mammalian hepatic Gal/GalNac-specific receptor. Glycoconjugate J. 4, 317-328.
12. Kornfeld, R., and Kornfeld, S. (1976) Comparative aspects of glycoprotein structure. Annu. Rev. Biochem. 45, 217-237.
13. Ponpipom, M., Bugianesi, R. L., Robbius, J. C., Doebber, T. W., and Shen, T. Y. (1981) Cell specific ligands for selective drug delivery to tissue and organs. J. Med. Chem. 24, 1388-1395.
14. Plank, C., Zatloukal, K., Cotton, M., Mechtler, K., and Wagner, E. (1992) Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. Bioconjugate Chem. 4, 85-93.
15. Haensler, J., and Szoka, F. C., Jr. (1993) Synthesis and characterization of a trigalactosylated bisacridine compound to target DNA to hepatocytes. Bioconjugate Chem. 4, 85-93.
16. 3, a synthetic glycopeptide ligand for the asialoglycoprotein receptor. Bioconjugate Chem. 5, 612-620.
17. 7, in the mouse. Antisense Nucleic Acid Drug Dev. 7, 141-149.
18. Leamon, C. P., and Low, P. S. (1993) Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells. Biochem. J. 291, 855-860.
19. Leamon, C. P., and Low, P. S. (1991) Delivery of macromolecules into living cells: A method that exploits folate receptor endocytosis. Proc. Natl. Acad. Sci. U.S.A. 88, 5572-5576.
20. Lee, R. J., and Low, P. S. (1994) Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 269, 3198-3204.
21. Citro, G., Szczylik, C., Ginobbi, P., Zupi, G., and Calabretta, B. (1994) Inhibition of leukemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells. Br. J. Cancer 69, 463-467.
22. Habus, I., Xie, J., Iyer, R. P., Zhou, W.-Q., Shen, L. X., and Agarwal, S. (1998) A mild and efficient solid-support synthesis of novel oligonucleotide conjugates. Bioconjugate Chem. 9, 283-291.
23. Harrison, J. G., and Balasubramanian, S. (1997) A convenient synthetic route to oligonucleotide conjugates. Bioorg. Med. Chem. Lett. 7, 1041-1046.
24. Bhat, B., Balow, G., Guzaev, A., Cook, D. P., and Manoharan, M. (1999) Synthesis of fully protected nucleoside-folic acid conjugated phosphoramidites and their incorporation into antisense oligonucleotides. Nucleosides Nucleotides 18, 1471-1472.
25. Wang, S., Mathias, C. J., Green, M. A., and Low, P. S. (1996) Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine-folate, a potential radiopharmaceutical for tumor imaging. Bioconjugate Chem. 8, 673-679.
26. Lacey, S. W., Sanders, J. M., Rothberg, K. G., Anderson, R. G. W., and Kamen, B. A. (1989) Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol. J. Clin. Invest. 84, 715-720.
27. Selhub, J., and Franklin, W. A. (1984) The folate-binding protein of rat kidney. Purification, properties and cellular distribution. J. Biol. Chem. 259, 6601-6606.
28. Asok, A. C., Utley, C., Van Horne, K. C., and Kolhouse, J. F. (1981) Isolation and characterisation of a folate receptor from human placenta. J. Biol. Chem. 256, 9684-9692.
29. Rothenberg, S. P., and Da Costa, M. (1971) Further observations on the folate binding factor in some leukemic cells. J. Clin. Invest. 50, 719-726.
30. Wincott, F. E., DiRenzo, A., Shaffer, C., Grimm, S., Tracz, D., Workman, C., Sweedler, D., Gonzalez, C., Scaringe, S., and Usman, N. (1995) Synthesis, deprotection, analysys and purification of RNA and ribozymes. Nucleic Acids Res. 23, 2677-2684.
31. Findeis, M. A. (1994) Stepwise synthesis of a GalNAc-containing cluster glycoside ligand of the asialoglycoprotein receptor. Int. J. Pept. Protein Res. 43, 477-485.
32. Matulic-Adamic, J., Beigelman, L., Dudycz, L. W., Gonzalez, C., and Usman, N. (1995) Synthesis and incorporation of 2′-amino acid conjugated nucleotides into ribozymes. Bioorg. Med. Chem. Lett. 5, 2721-2724.
33. Holt, D. A., Luengo, J. I., Yamashita, D. S., Oh, H.-J., Konialian, A. L., Yen, H.-K., Rozamus, L. W., Brandt, M., Bossard, M. J., Levy, M. A., Eggleston, D. S., Liang, J., Schultz, L. W., Stout, T. J., and Clardy, J. (1993) Design, synthesis, and kinetic evaluation of high-affinity FKBP ligands and the X-ray crystal structures of their complexes with FKBP12. J. Am. Chem. Soc. 115, 9925-9938.
34. Guzaev, A. P., Cook, P. D., Manoharan, M., and Bhat, B. (2002) Nucleosidic and nonnucleosidic folate conjugates, US Patent 6335434 B1.
35. Kuimelis, R. G., and McLaughlin, L. W. (1997) Probing the cleavage activity of the hammerhead ribozyme using analogue complexes, in Nucleic Acids and Molecular Biology. Catalytic RNA (F. Eckstein, and D. M. Lilley, Eds.) vol. 10, pp 197-215, Springer-Verlag, New York.
36. Sanghvi, Y., Guo, Z., Pfundheller, H. M., and Converso, A. (2000) Improved process for the preparation of nucleosidic phosphoramidites using a safer and cheaper activator. Org. Process Res. Dev. 4, 175-181.